{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T13:22:21Z","timestamp":1791638541619,"version":"4.3.4"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2018,4,22]],"date-time":"2018-04-22T00:00:00Z","timestamp":1524355200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Nucl Med Mol Imaging"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1007\/s00259-018-4018-z","type":"journal-article","created":{"date-parts":[[2018,4,21]],"date-time":"2018-04-21T22:03:11Z","timestamp":1524348191000},"page":"1772-1780","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":69,"title":["Challenging pre-surgical localization of hyperfunctioning parathyroid glands in primary hyperparathyroidism: the added value of 18F-Fluorocholine PET\/CT"],"prefix":"10.1007","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9549-5004","authenticated-orcid":false,"given":"Serena","family":"Grimaldi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacques","family":"Young","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Kamenicky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dana","family":"Hartl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Terroir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Leboulleux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amandine","family":"Berdelou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julien","family":"Hadoux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Segolene","family":"Hescot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herv\u00e9","family":"Remy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Baudin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Schlumberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D\u00e9sir\u00e9e","family":"Deandreis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,4,22]]},"reference":[{"issue":"9060","key":"4018_CR1","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1016\/S0140-6736(96)06176-4","volume":"349","author":"A Al Zahrani","year":"1997","unstructured":"Al Zahrani A, Levine MA. Primary hyperparathyroidism. Lancet. 1997;349(9060):1233\u20138.","journal-title":"Lancet"},{"issue":"8","key":"4018_CR2","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1007\/s00423-015-1342-7","volume":"400","author":"M Iacobone","year":"2015","unstructured":"Iacobone M, Carnaille B, Palazzo FF, Vriens M. Hereditary hyperparathyroidism\u2014a consensus report of the European Society of Endocrine Surgeons (ESES). Langenbecks Arch Surg. 2015;400(8):867\u201386.","journal-title":"Langenbecks Arch Surg"},{"issue":"10","key":"4018_CR3","doi-asserted-by":"publisher","first-page":"3561","DOI":"10.1210\/jc.2014-1413","volume":"99","author":"JP Bilezikian","year":"2014","unstructured":"Bilezikian JP, et al. Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the Fourth International Workshop. J Clin Endocrinol Metab. 2014;99(10):3561\u20139.","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"4018_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00198-016-3716-2","volume":"28","author":"AA Khan","year":"2017","unstructured":"Khan AA, et al. Primary hyperparathyroidism: review and recommendations on evaluation, diagnosis, and management. A Canadian and international consensus. Osteoporos Int. 2017;28(1):1.","journal-title":"Osteoporos Int"},{"issue":"6","key":"4018_CR5","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1001\/archsurg.2010.108","volume":"145","author":"DM Elaraj","year":"2010","unstructured":"Elaraj DM, et al. Are additional localization studies and referral indicated for patients with primary hyperparathyroidism who have negative sestamibi scan results? Arch Surg. 2010;145(6):578\u201381.","journal-title":"Arch Surg"},{"issue":"3","key":"4018_CR6","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1210\/jc.2012-3168","volume":"98","author":"JW Kunstman","year":"2013","unstructured":"Kunstman JW, Kirsch JD, Mahajan A, Udelsman R. Parathyroid localization and implications for clinical management. J Clin Endocrinol Metab. 2013;98(3):902\u201312.","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"4018_CR7","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1097\/RLU.0b013e318251e408","volume":"37","author":"D Taieb","year":"2012","unstructured":"Taieb D, Hindie E, Grassetto G, Colletti PM, Rubello D. Parathyroid scintigraphy: when, how, and why? A concise systematic review. Clin Nucl Med. 2012;37(6):568\u201374.","journal-title":"Clin Nucl Med"},{"issue":"10","key":"4018_CR8","first-page":"1801","volume":"33","author":"R Taillefer","year":"1992","unstructured":"Taillefer R, Boucher Y, Potvin C, Lambert R. Detection and localization of parathyroid adenomas in patients with hyperparathyroidism using a single radionuclide imaging procedure with technetium-99m-sestamibi (double-phase study). J Nucl Med. 1992;33(10):1801\u20137.","journal-title":"J Nucl Med"},{"issue":"S1","key":"4018_CR9","doi-asserted-by":"publisher","first-page":"E2159","DOI":"10.1002\/hed.24027","volume":"38","author":"G Treglia","year":"2016","unstructured":"Treglia G, et al. Detection rate of 99m Tc-MIBI single photon emission computed tomography (SPECT)\/CT in preoperative planning for patients with primary hyperparathyroidism: a meta-analysis. Head Neck. 2016;38(S1):E2159\u201372.","journal-title":"Head Neck"},{"issue":"10","key":"4018_CR10","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1007\/s12149-012-0643-y","volume":"26","author":"C Caldarella","year":"2012","unstructured":"Caldarella C, Treglia G, Pontecorvi A, Giordano A. Diagnostic performance of planar scintigraphy using 99mTc-MIBI in patients with secondary hyperparathyroidism: a meta-analysis. Ann Nucl Med. 2012;26(10):794\u2013803.","journal-title":"Ann Nucl Med"},{"issue":"1","key":"4018_CR11","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.yasu.2015.03.011","volume":"49","author":"RR Kelz","year":"2015","unstructured":"Kelz RR, Fraker DL. Hyperparathyroidism. Adv Surg. 2015;49(1):247\u201362.","journal-title":"Adv Surg"},{"issue":"2","key":"4018_CR12","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1245\/s10434-011-1870-5","volume":"19","author":"K Cheung","year":"2012","unstructured":"Cheung K, Wang TS, Farrokhyar F, Roman SA, Sosa JA. A meta-analysis of preoperative localization techniques for patients with primary hyperparathyroidism. Ann Surg Oncol. 2012;19(2):577\u201383.","journal-title":"Ann Surg Oncol"},{"issue":"9","key":"4018_CR13","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.1097\/MLG.0b013e31817aecad","volume":"118","author":"B Abboud","year":"2008","unstructured":"Abboud B, et al. Ultrasonography: highly accuracy technique for preoperative localization of parathyroid adenoma. Laryngoscope. 2008;118(9):1574\u20138.","journal-title":"Laryngoscope"},{"issue":"5","key":"4018_CR14","doi-asserted-by":"publisher","first-page":"539","DOI":"10.7863\/jum.2002.21.5.539","volume":"21","author":"SB Reeder","year":"2002","unstructured":"Reeder SB, Desser TS, Weigel RJ, Jeffrey RB. Sonography in primary hyperparathyroidism. J Ultrasound Med. 2002;21(5):539\u201352.","journal-title":"J Ultrasound Med"},{"issue":"1","key":"4018_CR15","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.amjsurg.2014.09.039","volume":"210","author":"PP Parikh","year":"2015","unstructured":"Parikh PP, Farra JC, Allan BJ, Lew JI. Long-term effectiveness of localization studies and intraoperative parathormone monitoring in patients undergoing reoperative parathyroidectomy for persistent or recurrent hyperparathyroidism. Am J Surg. 2015;210(1):117\u201322.","journal-title":"Am J Surg"},{"issue":"12","key":"4018_CR16","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1001\/archsurg.2011.837","volume":"146","author":"JJ Shin","year":"2011","unstructured":"Shin JJ, Milas M, Mitchell J, Berber E, Ross L, Siperstein A. Impact of localization studies and clinical scenario in patients with hyperparathyroidism being evaluated for reoperative neck surgery. Arch Surg. 2011;146(12):1397\u2013403.","journal-title":"Arch Surg"},{"issue":"6","key":"4018_CR17","doi-asserted-by":"publisher","first-page":"e328","DOI":"10.1097\/RLU.0b013e3182a77b62","volume":"39","author":"T Cazaentre","year":"2014","unstructured":"Cazaentre T, Clivaz F, Triponez F. False-positive result in 18F-fluorocholine PET\/CT due to incidental and ectopic parathyroid hyperplasia. Clin Nucl Med. 2014;39(6):e328\u201330.","journal-title":"Clin Nucl Med"},{"issue":"3","key":"4018_CR18","doi-asserted-by":"publisher","first-page":"228","DOI":"10.2478\/raon-2013-0075","volume":"48","author":"M Hodolic","year":"2014","unstructured":"Hodolic M, et al. Incidental uptake of 18F-fluorocholine (FCH) in the head or in the neck of patients with prostate cancer. Radiol Oncol. 2014;48(3):228.","journal-title":"Radiol Oncol"},{"issue":"6","key":"4018_CR19","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1097\/RLU.0b013e31824c5ffc","volume":"37","author":"P Mapelli","year":"2012","unstructured":"Mapelli P, et al. Incidental finding of parathyroid adenoma with 11C-choline PET\/CT. Clin Nucl Med. 2012;37(6):593\u20135.","journal-title":"Clin Nucl Med"},{"issue":"8","key":"4018_CR20","doi-asserted-by":"publisher","first-page":"3111","DOI":"10.1210\/jc.2013-2084","volume":"98","author":"E Quak","year":"2013","unstructured":"Quak E, Lheureux S, Reznik Y, Bardet S, Aide N. F18-choline, a novel PET tracer for parathyroid adenoma? J Clin Endocrinol Metab. 2013;98(8):3111\u20132.","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"4018_CR21","doi-asserted-by":"publisher","first-page":"2083","DOI":"10.1007\/s00259-014-2837-0","volume":"41","author":"L Lezaic","year":"2014","unstructured":"Lezaic L, Rep S, Sever MJ, Kocjan T, Hocevar M, Fettich J. 18F-Fluorocholine PET\/CT for localization of hyperfunctioning parathyroid tissue in primary hyperparathyroidism: a pilot study. Eur J Nucl Med Mol Imaging. 2014;41(11):2083\u20139.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"41","key":"4018_CR22","doi-asserted-by":"publisher","first-page":"e1701","DOI":"10.1097\/MD.0000000000001701","volume":"94","author":"L Michaud","year":"2015","unstructured":"Michaud L, et al. A pilot comparison of 18F-fluorocholine PET\/CT, ultrasonography and 123I\/99mTc-sestaMIBI dual-phase dual-isotope scintigraphy in the preoperative localization of hyperfunctioning parathyroid glands in primary or secondary hyperparathyroidism: influence of thyroid anomalies. Medicine (Baltimore). 2015;94(41):e1701.","journal-title":"Medicine (Baltimore)"},{"issue":"12","key":"4018_CR23","doi-asserted-by":"publisher","first-page":"4531","DOI":"10.1210\/jc.2014-2821","volume":"99","author":"L Michaud","year":"2014","unstructured":"Michaud L, et al. Is 18F-fluorocholine-positron emission tomography\/computerized tomography a new imaging tool for detecting Hyperfunctioning parathyroid glands in primary or secondary hyperparathyroidism? J Clin Endocrinol Metab. 2014;99(12):4531\u20136.","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"4018_CR24","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1007\/s00259-009-1131-z","volume":"36","author":"E Hindi\u00e9","year":"2009","unstructured":"Hindi\u00e9 E, et al. 2009 EANM parathyroid guidelines. Eur J Nucl Med Mol Imaging. 2009;36(7):1201\u201316.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"9","key":"4018_CR25","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.1016\/j.ejrad.2015.05.024","volume":"84","author":"WP Kluijfhout","year":"2015","unstructured":"Kluijfhout WP, Vorselaars WMCM, Vriens MR, Borel Rinkes IHM, Valk GD, de Keizer B. Enabling minimal invasive parathyroidectomy for patients with primary hyperparathyroidism using Tc-99m-sestamibi SPECT\u2013CT, ultrasound and first results of 18F-fluorocholine PET\u2013CT. Eur J Radiol. 2015;84(9):1745\u201351.","journal-title":"Eur J Radiol"},{"issue":"4","key":"4018_CR26","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1007\/s11864-004-0024-4","volume":"5","author":"NR Caron","year":"2004","unstructured":"Caron NR, Sturgeon C, Clark OH. Persistent and recurrent hyperparathyroidism. Curr Treat Options Oncol. 2004;5(4):335\u201345.","journal-title":"Curr Treat Options Oncol"},{"issue":"Suppl 2","key":"4018_CR27","first-page":"N158","volume":"17","author":"SJ Wells","year":"2002","unstructured":"Wells SJ, Debenedetti M, Doherty G. Recurrent or persistent hyperparathyroidism. J Bone Min Res. 2002;17(Suppl 2):N158\u201362.","journal-title":"J Bone Min Res"},{"issue":"12","key":"4018_CR28","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1097\/RLU.0000000000000607","volume":"39","author":"M Orevi","year":"2014","unstructured":"Orevi M, Freedman N, Mishani E, Bocher M, Jacobson O, Krausz Y. Localization of parathyroid adenoma by 11C-choline PET\/CT: preliminary results. Clin Nucl Med. 2014;39(12):1033\u20138.","journal-title":"Clin Nucl Med"},{"issue":"12","key":"4018_CR29","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1097\/MNM.0000000000000595","volume":"37","author":"WP Kluijfhout","year":"2016","unstructured":"Kluijfhout WP, et al. Fluorine-18 fluorocholine PET-CT localizes hyperparathyroidism in patients with inconclusive conventional imaging: a multicenter study from the Netherlands. Nucl Med Commun. 2016;37(12):1246\u201352.","journal-title":"Nucl Med Commun"},{"key":"4018_CR30","doi-asserted-by":"publisher","unstructured":"Quak E, et al. F18-choline PET\/CT guided surgery in primary hyperparathyroidism when ultrasound and MIBI SPECT\/CT are negative or inconclusive: the APACH1 study. Eur J Nucl Med Mol Imaging. 2018; \n                    https:\/\/doi.org\/10.1007\/s00259-017-3911-1\n                    \n                  .","DOI":"10.1007\/s00259-017-3911-1"},{"issue":"1","key":"4018_CR31","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.ejso.2016.09.016","volume":"43","author":"M Hocevar","year":"2017","unstructured":"M. Hocevar, et al. Focused parathyroidectomy without intraoperative parathormone testing is safe after pre-operative localization with 18F-Fluorocholine PET\/CT. Eur J Surg Oncol. 2017;43(1):133\u20137.","journal-title":"Eur J Surg Oncol"},{"issue":"12","key":"4018_CR32","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.1007\/s00259-015-3130-6","volume":"42","author":"D Deandreis","year":"2015","unstructured":"Deandreis D, et al. 18Fluorocholine PET\/CT in parathyroid carcinoma: a new tool for disease staging? Eur J Nucl Med Mol Imaging. 2015;42(12):1941\u20132.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"4018_CR33","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1097\/RLU.0000000000000988","volume":"41","author":"M Krakauer","year":"2016","unstructured":"Krakauer M, Wieslander B, Myschetzky PS, Lundstr\u00f8m A, Bacher T, S\u00f8rensen CH, et al. A prospective comparative study of parathyroid dual-phase scintigraphy, dual-isotope subtraction scintigraphy, 4D-CT, and ultrasonography in primary hyperparathyroidism. Clin Nucl Med. 2016;41:93\u2013100.","journal-title":"Clin Nucl Med"},{"issue":"1","key":"4018_CR34","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1007\/s12020-012-9746-4","volume":"43","author":"C Caldarella","year":"2013","unstructured":"Caldarella C, Treglia G, Isgr\u00f2 MA, Giordano A. Diagnostic performance of positron emission tomography using 11C-methionine in patients with suspected parathyroid adenoma: a meta-analysis. Endocrine. 2013;43(1):78\u201383.","journal-title":"Endocrine"},{"issue":"3","key":"4018_CR35","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1177\/0194599815618199","volume":"154","author":"S Merchavy","year":"2016","unstructured":"Merchavy S, Luckman J, Guindy M, Segev Y, Khafif A. 4D MRI for the localization of parathyroid adenoma: a novel method in evolution. Otolaryngol Head Neck Surg. 2016;154(3):446\u20138.","journal-title":"Otolaryngol Head Neck Surg"},{"issue":"3","key":"4018_CR36","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1007\/s00330-015-3854-5","volume":"26","author":"B Sacconi","year":"2016","unstructured":"Sacconi B, et al. MR appearance of parathyroid adenomas at 3 T in patients with primary hyperparathyroidism: what radiologists need to know for pre-operative localization. Eur Radiol. 2016;26(3):664\u201373.","journal-title":"Eur Radiol"}],"container-title":["European Journal of Nuclear Medicine and Molecular Imaging"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00259-018-4018-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-018-4018-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-018-4018-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,21]],"date-time":"2019-04-21T19:07:43Z","timestamp":1555873663000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00259-018-4018-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,22]]},"references-count":36,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2018,9]]}},"alternative-id":["4018"],"URL":"https:\/\/doi.org\/10.1007\/s00259-018-4018-z","relation":{},"ISSN":["1619-7070","1619-7089"],"issn-type":[{"value":"1619-7070","type":"print"},{"value":"1619-7089","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,4,22]]},"assertion":[{"value":"27 December 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 April 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Serena Grimaldi declares that she has no conflict of interest, Jacques Young declares that he has no conflict of interest, Peter Kamenicky declares that he has no conflict of interest, Dana Hartl declares that she has no conflict of interest, Marie Terroir declares that she has no conflict of interest, Sophie Leboulleux declares that she has no conflict of interest, Amandine Berdelou declares that she has no conflict of interest, Julien Hadoux declares that he has no conflict of interest, Segolene Hescot declares that she has no conflict of interest, Herv\u00e9 Remy declares that he has no conflict of interest, Eric Baudin declares that he has no conflict of interest, Martin Schlumberger declares that he has no conflict of interest, D\u00e9sir\u00e9e Deandreis declares that she has no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}